PhaseⅠStudy of the HS-10241 in Patients With Advanced Solid Tumors

NCT04477057 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: HS-10241

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.